Trial Profile
A Placebo-controlled Dose-finding Study for SPM 962 in Advanced Parkinson's Disease Patients With Concomitant Treatment of L-dopa
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Aug 2018
Price :
$35
*
At a glance
- Drugs Rotigotine (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions; Therapeutic Use
- Sponsors Otsuka Pharmaceutical
- 03 Jul 2012 New trial record